The latest filing does not contain sufficient reviewed comparable structured data
Last SEC check
Sep 13, 2026
Filing → research
8 min
Data basis
Official SEC · no quote feed
Component status
Filing EvidenceResearch CurrentOfficial SEC filing history is available
Structured FinancialsSource LimitedThe latest filing model has no reviewed comparable financial mapping · NO_CURRENT_COMPARABLE_STATE
Filing AnalysisSource LimitedNo filing analysis job is currently running · NO_CURRENT_COMPARABLE_STATE
Fundamental StateSource LimitedFundamental State depends on validated comparable financial metrics · NO_CURRENT_COMPARABLE_STATE
RESEARCH SNAPSHOTRein Therapeutics, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
Flagship analysis / V3
What changed?
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q0001193125-26-35027013 governed changes · top 7 shown
01
HIGH IMPORTANCEFinancial Value100TH HISTORICAL PCTL · N=4
Current assets increased 527.9%
Current assets changed +527.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
HIGH IMPORTANCEFinancial Value100TH HISTORICAL PCTL · N=4
Current ratio increased 397.6%
Current ratio changed +397.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
As-filed financials
Financial trajectory
Each point keeps the date investors could first observe it and its accession.
As filedCurrent normalized · later
ACTIVE TRACE
Revenue
RNTX · as filed with the SEC · reported-date aware
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
HIGH IMPORTANCEFinancial Value100TH HISTORICAL PCTL · N=4
Working capital / assets moved 5002 bp higher
Working capital / assets changed +5002 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash flow changed -34.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
MEDIUM IMPORTANCEFinancial Value100TH HISTORICAL PCTL · N=4
Working capital changed across a sign change
Working capital changed +3007.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 4 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.